Main description:

This new volume updates the reader on the therapeutic options available, with special emphasis on combination therapies, mechanisms of resistance and the possible future impact of pharmacogenetics on clinical efficacy. This comprehensive review of targeted therapies will guide the reader on effective treatment as part of an integrated programme of patient management. In-depth review of available targeted therapies, covering all the main breast cancer subtypes. Addresses possible future development in combination therapies and the role of pharmacogenetics.

Contents:

1. Overcoming resistance, N Sharma 2. HER2 therapy, MD Pegram 3. Targeting prevention therapies, L Wickerham 4. Combining targeted therapies, C Arteaga 5. HER2 resistance, F Cardoso 6. Triple negative breast cancer, AM Gonzalez-Angulo 7. Chemotherapy as targeted therapy, L Pusztai 8. Pharmacogenomics and therapeutic targeting, D Flockhart Abbreviations Index